Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes

Ohio State University Comprehensive Cancer Center · 2008
ClinicalTrials.gov · Datasets · License: Public Domain · 2008
Open Source ↗
leukemiaq12
leukemia, myelodysplastic syndromes, myelodysplastic/myeloproliferative neoplasms, adult acute myeloid leukemia with 11q23 (mll) abnormalities, adult acute myeloid leukemia with inv(16)(p13;q22), adult acute myeloid leukemia with t(15;17)(q22;q12), adult acute myeloid leukemia with t(16;16)(p13;q22), adult acute myeloid leukemia with t(8;21)(q22;q22), recurrent adult acute myeloid leukemia, myelodysplastic/myeloproliferative neoplasm, unclassifiable, secondary acute myeloid leukemia, interventional
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 849188
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.